pyrazinamide has been researched along with Pancreatic Neoplasms in 3 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, J | 1 |
| Kyani, A | 1 |
| Hanafi, M | 1 |
| Xu, Y | 1 |
| Takyi-Williams, J | 1 |
| Sun, D | 1 |
| Osman, EEA | 1 |
| Neamati, N | 1 |
| Kiziltaş, Ş | 1 |
| Çolak, Y | 1 |
| Ulaşoğlu, C | 1 |
| Öztürk, O | 1 |
| Yorulmaz, E | 1 |
| Adali, G | 1 |
| Enç, F | 1 |
| Tuncer, İ | 1 |
| Doi, K | 1 |
3 other studies available for pyrazinamide and Pancreatic Neoplasms
| Article | Year |
|---|---|
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.
Topics: Copper; Humans; Ligands; Pancreatic Neoplasms; Pyrazinamide; Receptors, sigma | 2023 |
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.
Topics: Copper; Humans; Ligands; Pancreatic Neoplasms; Pyrazinamide; Receptors, sigma | 2023 |
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.
Topics: Copper; Humans; Ligands; Pancreatic Neoplasms; Pyrazinamide; Receptors, sigma | 2023 |
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.
Topics: Copper; Humans; Ligands; Pancreatic Neoplasms; Pyrazinamide; Receptors, sigma | 2023 |
A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Diagnosis, Differential; Drug Therapy, Combination | 2011 |
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; | 1975 |